We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
New insights in insurmountable antagonism.
- Authors
Vauquelin, G; Van Liefde, I; Birzbier, B B; Vanderheyden, P M L
- Abstract
Antagonists that produce parallel rightward shifts of agonist dose-response curves with no alteration of the maximal response are traditionally classified as surmountable, while insurmountable antagonists also depress the maximal response. Although the longevity of the antagonist-receptor complex is quoted in many studies to explain insurmountable antagonism, slowly interconverting receptor conformations, allosteric binding sites, and receptor internalization have been evoked as alternative explanations. To complicate matters even further, insurmountable antagonism is not only drug-related; it may also depend on the tissue, species and experimental design. For the sake of drug development, it is important to elucidate the molecular mechanisms of insurmountable antagonism. New experimental approaches, such as intact cell studies and the use of computer-assisted simulations based on dynamic receptor models, herald the advent of better insight in the future.
- Publication
Fundamental & clinical pharmacology, 2002, Vol 16, Issue 4, p263
- ISSN
0767-3981
- Publication type
Journal Article
- DOI
10.1046/j.1472-8206.2002.00095.x